Translational and tailored, but can we afford it?
17 Jul 2012
Translational and tailored, but can we afford it?
Cost efficiency of targeted therapy
Society and money - the cancer conundrum
Translating cancer research to personalised treatment: Can it work?
Constructing successful biomarker clinical trials
The changing field of drug development
Young Voices United against CRC
Advances in radiotherapy for rectal cancer
Important to support young medical oncologists’ research
The WINTHER study
Use of electronic data to raise the standard of cancer care
Drugging the cancer genome: opportunities and challenges